Final Notes Semaglutide exercise and muscle planning should feel simple and repeatable
Abstract Objectives: Semaglutide is a glucagon-like peptide 1 receptor agonist that improves glycemic control and achieves weight loss in type 2 diabetes (T2D) patients
The FDA has issued specific guidance on compounded semaglutide, noting that compounded versions are not FDA-approved and have not undergone the same safety and efficacy testing as Novo Nordisk's Ozempic or Wegovy [12]
The difference is that semaglutide is already FDA approved, widely prescribed, and proven to reduce both weight and cardiovascular risk
Beyond the usual education on topics like portion control and mindful eating, it may be time to discuss options including hormone therapy and prescription weight loss medications
SSRIs and SNRIs , the most commonly prescribed antidepressants in the UK, generally have a neutral or potentially beneficial effect on glycaemic control in some individuals